David W. Cope
MRC Anatomical Neuropharmacology Unit
Department of Pharmacology
Oxford University
Mansfield Road
UK
Name/email consistency: high
- Loss of zolpidem efficacy in the hippocampus of mice with the GABAA receptor gamma2 F77I point mutation. Cope, D.W., Halbsguth, C., Karayannis, T., Wulff, P., Ferraguti, F., Hoeger, H., Leppä, E., Linden, A.M., Oberto, A., Ogris, W., Korpi, E.R., Sieghart, W., Somogyi, P., Wisden, W., Capogna, M. Eur. J. Neurosci. (2005)
- GABAA receptor-mediated tonic inhibition in thalamic neurons. Cope, D.W., Hughes, S.W., Crunelli, V. J. Neurosci. (2005)
- Abolition of zolpidem sensitivity in mice with a point mutation in the GABAA receptor gamma2 subunit. Cope, D.W., Wulff, P., Oberto, A., Aller, M.I., Capogna, M., Ferraguti, F., Halbsguth, C., Hoeger, H., Jolin, H.E., Jones, A., McKenzie, A.N., Ogris, W., Poeltl, A., Sinkkonen, S.T., Vekovischeva, O.Y., Korpi, E.R., Sieghart, W., Sigel, E., Somogyi, P., Wisden, W. Neuropharmacology (2004)